Chad Messer
Stock Analyst at Lake Street
(1.01)
# 3,954
Out of 4,690 analysts
500
Total ratings
38%
Success rate
-0.5%
Average return
Main Sectors:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEN Compugen | Reiterated: Buy | $5 → $6 | $2.60 | +130.77% | 4 | Jul 21, 2026 | |
| OSTX OS Therapies | Maintained: Buy | $13 | $1.64 | +692.68% | 19 | Jul 7, 2026 | |
| CNSY Cerenome | Reiterated: Buy | $50 | $3.05 | +1,539.34% | 6 | Jul 1, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $103 | $111.89 | -7.95% | 7 | Jun 30, 2026 | |
| GNLX Genelux | Maintained: Buy | $16 | $2.66 | +501.50% | 6 | Jun 30, 2026 | |
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $32 | $13.58 | +135.64% | 1 | Jun 11, 2026 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $5 | $0.8566 | +483.70% | 18 | Jun 1, 2026 | |
| IMNM Immunome | Maintained: Buy | $30 | $27.57 | +8.81% | 9 | Jun 1, 2026 | |
| COYA Coya Therapeutics | Maintained: Buy | $17 | $4.59 | +270.37% | 14 | May 22, 2026 | |
| LTRN Lantern Pharma | Maintained: Buy | $25 | $2.07 | +1,107.73% | 13 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $3.82 | +1,865.92% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.55 | - | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $9.60 | n/a | 18 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 340.00 → kr 380.00 | kr 213.40 | n/a | 13 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.51 | n/a | 17 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $8.30 | n/a | 7 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $7.04 | n/a | 5 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.000001 | n/a | 11 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 | $88.44 | n/a | 2 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $72.09 | n/a | 31 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $6.09 | n/a | 13 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.8786 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $90.36 | n/a | 19 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $2.34 | n/a | 17 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.95 | n/a | 25 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $84 | $61.05 | n/a | 50 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.000001 | n/a | 17 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 | $26.21 | n/a | 6 | Jul 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $30 | $54.45 | n/a | 22 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $83 | $1.84 | n/a | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $166 | $20.86 | n/a | 50 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.2525 | n/a | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.32 | n/a | 21 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.62 | n/a | 3 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $27 | $13.73 | n/a | 3 | Apr 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $33 | $8.10 | n/a | 10 | Dec 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.00004 | n/a | 5 | May 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $4 | $13.21 | n/a | 6 | Mar 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.32 | n/a | 1 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.53 | n/a | 1 | May 22, 2012 |
Compugen
Jul 21, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $2.60
Upside: +130.77%
OS Therapies
Jul 7, 2026
Maintained: Buy
Price Target: $13
Current: $1.64
Upside: +692.68%
Cerenome
Jul 1, 2026
Reiterated: Buy
Price Target: $50
Current: $3.05
Upside: +1,539.34%
Monopar Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $103
Current: $111.89
Upside: -7.95%
Genelux
Jun 30, 2026
Maintained: Buy
Price Target: $16
Current: $2.66
Upside: +501.50%
Kazia Therapeutics
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.58
Upside: +135.64%
Oncolytics Biotech
Jun 1, 2026
Maintained: Buy
Price Target: $5
Current: $0.8566
Upside: +483.70%
Immunome
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $27.57
Upside: +8.81%
Coya Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $17
Current: $4.59
Upside: +270.37%
Lantern Pharma
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $2.07
Upside: +1,107.73%
May 13, 2026
Maintained: Buy
Price Target: $75
Current: $3.82
Upside: +1,865.92%
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.55
Upside: -
Nov 1, 2021
Maintained: Buy
Price Target: $6 → $7
Current: $9.60
Upside: n/a
Sep 1, 2021
Reiterated: Buy
Price Target: kr 340.00 → kr 380.00
Current: kr 213.40
Upside: n/a
Aug 17, 2021
Rated: Buy
Price Target: $3
Current: $1.51
Upside: n/a
Aug 13, 2021
Maintained: Buy
Price Target: $29
Current: $8.30
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $49
Current: $7.04
Upside: n/a
Aug 10, 2021
Maintained: Buy
Price Target: $5
Current: $0.000001
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $50
Current: $88.44
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $48
Current: $72.09
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $30
Current: $6.09
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $10
Current: $0.8786
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $12
Current: $90.36
Upside: n/a
Aug 5, 2021
Rated: Buy
Price Target: $21
Current: $2.34
Upside: n/a
Aug 4, 2021
Rated: Hold
Price Target: n/a
Current: $40.95
Upside: n/a
Aug 4, 2021
Rated: Buy
Price Target: $84
Current: $61.05
Upside: n/a
Jul 29, 2021
Rated: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Jul 15, 2021
Rated: Buy
Price Target: $48
Current: $26.21
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $33 → $30
Current: $54.45
Upside: n/a
Jun 7, 2021
Reiterated: Buy
Price Target: $75 → $83
Current: $1.84
Upside: n/a
May 18, 2021
Reiterated: Buy
Price Target: $166
Current: $20.86
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $10
Current: $0.2525
Upside: n/a
May 10, 2021
Rated: Hold
Price Target: n/a
Current: $33.32
Upside: n/a
Nov 8, 2019
Rated: Hold
Price Target: n/a
Current: $4.62
Upside: n/a
Apr 12, 2018
Maintained: Buy
Price Target: $30 → $27
Current: $13.73
Upside: n/a
Dec 9, 2016
Reiterated: Buy
Price Target: $6 → $33
Current: $8.10
Upside: n/a
May 7, 2015
Reiterated: Buy
Price Target: $10 → $7
Current: $0.00004
Upside: n/a
Mar 6, 2015
Maintained: Buy
Price Target: $7 → $4
Current: $13.21
Upside: n/a
Jan 5, 2015
Initiated Coverage: Buy
Price Target: $17
Current: $1.32
Upside: n/a
May 22, 2012
Initiated Coverage: Buy
Price Target: $5
Current: $1.53
Upside: n/a